Is BridgeBio Oncology Therapeutics Inc. (BBOT) a Buy, Sell, or Hold?
BridgeBio Oncology Therapeutics Inc.
NASDAQ:BBOT
$8.41 USD
-$0.41 (-4.65%)
- Volume
- 457.22K
- Average Volume
- 472.3K
- Market Capitalization
- $673.7M
- P/E Ratio
- -1.47
- Dividend Yield
- 0.00%
- Price Target
- $23.00
- Year High
- $14.87
- Year Low
- $7.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.16
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
36
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
10
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 5.84M
BBOT Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
BBOT Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Cobo Marc | officer: Principal Accounting Officer | 2026-07-01 | F-InKind | 7.8 | 2026-07-06 |
| Elmelech Idan | officer: COO & Principal Financial Ofcr | 2026-07-01 | F-InKind | 7.8 | 2026-07-06 |
| Ben Yong | officer: Chief Med & Dev Officer | 2026-07-01 | F-InKind | 7.8 | 2026-07-06 |
| Beltran Pedro | director, officer: President and CEO | 2026-07-01 | F-InKind | 7.8 | 2026-07-06 |
| Chen Bihua | director, 10 percent owner: | 2026-07-01 | J-Other | 0 | 2026-07-06 |
| Chen Bihua | director, 10 percent owner: | 2026-07-01 | J-Other | 0 | 2026-07-06 |
| Chen Bihua | director, 10 percent owner: | 2026-07-01 | J-Other | 0 | 2026-07-06 |
| Chen Bihua | director, 10 percent owner: | 2026-07-01 | J-Other | 0 | 2026-07-06 |
| Tipirneni Praveen P. | director | 2026-06-16 | A-Award | 7.73 | 2026-06-18 |
| MCCORMICK FRANK | director | 2026-06-16 | A-Award | 7.73 | 2026-06-18 |
| Lebowitz Peter F | director | 2026-06-16 | A-Award | 7.73 | 2026-06-18 |
| Kelleher Raymond J. | director | 2026-06-16 | A-Award | 7.73 | 2026-06-18 |
| Chen Bihua | director, 10 percent owner: | 2026-06-16 | A-Award | 7.73 | 2026-06-18 |
| Bauer Jake | director | 2026-06-16 | A-Award | 7.73 | 2026-06-18 |
| Kumar Neil | director | 2026-06-16 | A-Award | 7.73 | 2026-06-18 |
| Elmelech Idan | officer: COO & Principal Financial Ofcr | 2026-05-10 | A-Award | 7.66 | 2026-05-12 |
| Beltran Pedro | director, officer: President and CEO | 2026-05-10 | A-Award | 7.66 | 2026-05-12 |
| Ben Yong | officer: Chief Med & Dev Officer | 2026-04-01 | F-InKind | 9.03 | 2026-05-05 |
| Beltran Pedro | director, officer: President and CEO | 2026-04-01 | F-InKind | 9.03 | 2026-05-05 |
| Mehra Uneek | other: Former Officer | 2026-04-01 | F-InKind | 9.03 | 2026-05-05 |
| Cobo Marc | officer: Principal Accounting Officer | 2026-04-21 | 0 | 2026-04-30 | |
| Cobo Marc | officer: Principal Accounting Officer | 2026-04-21 | 9.59 | 2026-04-30 | |
| Cobo Marc | officer: Principal Accounting Officer | 2026-04-21 | 10.19 | 2026-04-30 | |
| Elmelech Idan | officer: COO & Principal Financial Ofcr | 2026-04-20 | 0 | 2026-04-30 | |
| Elmelech Idan | officer: COO & Principal Financial Ofcr | 2026-04-20 | 4.17 | 2026-04-30 | |
| Elmelech Idan | officer: COO & Principal Financial Ofcr | 2026-04-20 | 7.88 | 2026-04-30 | |
| Elmelech Idan | officer: COO & Principal Financial Ofcr | 2026-04-20 | 9.59 | 2026-04-30 | |
| Elmelech Idan | officer: COO & Principal Financial Ofcr | 2026-04-20 | 10.19 | 2026-04-30 | |
| Lebowitz Peter F | director | 2026-03-24 | A-Award | 8.72 | 2026-03-26 |
| Lebowitz Peter F | 2026-03-24 | 0 | 2026-03-26 | ||
| Mehra Uneek | officer: Chief Financial Officer | 2026-03-10 | A-Award | 10.19 | 2026-03-12 |
| Mehra Uneek | officer: Chief Financial Officer | 2026-03-10 | A-Award | 0 | 2026-03-12 |
| Beltran Pedro | officer: Chief Scientific Officer | 2026-03-10 | A-Award | 10.19 | 2026-03-12 |
| Beltran Pedro | officer: Chief Scientific Officer | 2026-03-10 | A-Award | 0 | 2026-03-12 |
| Ben Yong | officer: Chief Med & Dev Officer | 2026-03-10 | A-Award | 10.19 | 2026-03-12 |
| Ben Yong | officer: Chief Med & Dev Officer | 2026-03-10 | A-Award | 0 | 2026-03-12 |
| Wallace Eli M. | director, officer: Chief Executive Officer | 2026-01-01 | A-Award | 12.52 | 2026-01-05 |
| Wallace Eli M. | director, officer: Chief Executive Officer | 2025-12-10 | D-Return | 12.44 | 2025-12-12 |
| BridgeBio Pharma LLC | 10 percent owner | 2025-10-10 | J-Other | 0 | 2025-10-16 |
| Wallace Eli M. | director, officer: Chief Executive Officer | 2025-10-02 | A-Award | 12.44 | 2025-10-06 |
| Tipirneni Praveen P. | director | 2025-08-26 | A-Award | 9.59 | 2025-08-28 |
| MCCORMICK FRANK | director | 2025-08-26 | A-Award | 9.59 | 2025-08-28 |
| Bauer Jake | director | 2025-08-26 | A-Award | 9.59 | 2025-08-28 |
| Beltran Pedro | officer: Chief Scientific Officer | 2025-08-26 | A-Award | 9.59 | 2025-08-28 |
| Ben Yong | officer: Chief Med & Dev Officer | 2025-08-26 | A-Award | 9.59 | 2025-08-28 |
| Wallace Eli M. | director, officer: Chief Executive Officer | 2025-08-26 | A-Award | 9.59 | 2025-08-28 |
| Mehra Uneek | officer: Chief Financial Officer | 2025-08-26 | A-Award | 9.59 | 2025-08-28 |
| Tipirneni Praveen P. | director | 2025-08-11 | 7.88 | 2025-08-18 | |
| Tipirneni Praveen P. | director | 2025-08-11 | 5.18 | 2025-08-18 | |
| DOIG MICHELLE | 2025-08-11 | 0 | 2025-08-18 | ||
| MCCORMICK FRANK | director | 2025-08-11 | 4.17 | 2025-08-18 | |
| MCCORMICK FRANK | director | 2025-08-11 | 7.88 | 2025-08-18 | |
| BridgeBio Pharma LLC | 10 percent owner | 2025-08-11 | 0 | 2025-08-18 | |
| BridgeBio Pharma LLC | 10 percent owner | 2025-08-11 | 3.83 | 2025-08-18 | |
| BridgeBio Pharma LLC | 10 percent owner | 2025-08-11 | 1.02 | 2025-08-18 | |
| Bauer Jake | 2025-08-11 | 0 | 2025-08-18 | ||
| Kumar Neil | 2025-08-11 | 0 | 2025-08-18 | ||
| Ben Yong | officer: Chief Med & Dev Officer | 2025-08-11 | 4.17 | 2025-08-18 | |
| Ben Yong | officer: Chief Med & Dev Officer | 2025-08-11 | 7.88 | 2025-08-18 | |
| Wallace Eli M. | director, officer: Chief Executive Officer | 2025-08-11 | 4.17 | 2025-08-18 | |
| Wallace Eli M. | director, officer: Chief Executive Officer | 2025-08-11 | 7.88 | 2025-08-18 | |
| Mehra Uneek | 2025-08-11 | 0 | 2025-08-18 | ||
| Beltran Pedro | officer: Chief Scientific Officer | 2025-08-11 | 7.88 | 2025-08-18 | |
| Beltran Pedro | officer: Chief Scientific Officer | 2025-08-11 | 4.17 | 2025-08-18 | |
| Chen Bihua | director, 10 percent owner: | 2025-08-11 | A-Award | 0 | 2025-08-13 |
| Chen Bihua | director, 10 percent owner: | 2025-08-11 | A-Award | 10.7173 | 2025-08-13 |
| Chen Bihua | director, 10 percent owner: | 2025-08-11 | M-Exempt | 0.0001 | 2025-08-13 |
| Chen Bihua | director, 10 percent owner: | 2025-08-11 | D-Return | 0 | 2025-08-13 |
| Chen Bihua | director, 10 percent owner: | 2025-08-11 | D-Return | 0 | 2025-08-13 |
| Chen Bihua | director, 10 percent owner: | 2025-08-11 | A-Award | 0 | 2025-08-13 |
| Chen Bihua | director, 10 percent owner: | 2025-08-11 | A-Award | 10.7173 | 2025-08-13 |
| Chen Bihua | director, 10 percent owner: | 2025-08-11 | A-Award | 0 | 2025-08-13 |
| Chen Bihua | director, 10 percent owner: | 2025-08-11 | A-Award | 10.7173 | 2025-08-13 |
| Chen Bihua | director, 10 percent owner: | 2025-08-11 | M-Exempt | 0 | 2025-08-13 |
| Kelleher Raymond J. | director: | 2025-08-11 | 0 | 2025-08-11 | |
| Obradovic Nebojsa | officer | 2025-08-11 | 0 | 2025-08-11 | |
| Tripp Caleb | officer | 2025-08-11 | 0 | 2025-08-11 | |
| Holman Albert A III | other: Former Director | 2025-08-11 | M-Exempt | 0 | 2025-08-11 |
| Holman Albert A III | other: Former Director | 2025-08-11 | M-Exempt | 0 | 2025-08-11 |
| McKenna Mark C. | other: Former Director | 2025-08-11 | M-Exempt | 0 | 2025-08-11 |
| McKenna Mark C. | other: Former Director | 2025-08-11 | M-Exempt | 0 | 2025-08-11 |
| Schmid John P. | other: Former Director | 2025-08-11 | M-Exempt | 0 | 2025-08-11 |
| Schmid John P. | other: Former Director | 2025-08-11 | M-Exempt | 0 | 2025-08-11 |